133 related articles for article (PubMed ID: 26728967)
1. Probing the interaction between cHAVc3 peptide and the EC1 domain of E-cadherin using NMR and molecular dynamics simulations.
Alaofi A; Farokhi E; Prasasty VD; Anbanandam A; Kuczera K; Siahaan TJ
J Biomol Struct Dyn; 2017 Jan; 35(1):92-104. PubMed ID: 26728967
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.
Alaofi A; On N; Kiptoo P; Williams TD; Miller DW; Siahaan TJ
J Pharm Sci; 2016 Feb; 105(2):797-807. PubMed ID: 26869430
[TBL] [Abstract][Full Text] [Related]
3. (1)H, (13)C and (15)N backbone assignment of the EC-1 domain of human E-cadherin.
Prasasty VD; Krause ME; Tambunan US; Anbanandam A; Laurence JS; Siahaan TJ
Biomol NMR Assign; 2015 Apr; 9(1):31-5. PubMed ID: 24510398
[TBL] [Abstract][Full Text] [Related]
4. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
[TBL] [Abstract][Full Text] [Related]
5. Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies.
Civera M; Vasile F; Potenza D; Colombo C; Parente S; Vettraino C; Prosdocimi T; Parisini E; Belvisi L
PLoS Comput Biol; 2019 Jun; 15(6):e1007041. PubMed ID: 31158220
[TBL] [Abstract][Full Text] [Related]
6. Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers.
Makagiansar IT; Avery M; Hu Y; Audus KL; Siahaan TJ
Pharm Res; 2001 Apr; 18(4):446-53. PubMed ID: 11451030
[TBL] [Abstract][Full Text] [Related]
7. Solution structure and in silico binding of a cyclic peptide with hepatitis B surface antigen.
Muhamad A; Ho KL; Rahman MB; Uhrín D; Tan WS
Chem Biol Drug Des; 2013 Jun; 81(6):784-94. PubMed ID: 23405984
[TBL] [Abstract][Full Text] [Related]
8. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
9. Role of electrostatic interactions in binding of peptides and intrinsically disordered proteins to their folded targets. 1. NMR and MD characterization of the complex between the c-Crk N-SH3 domain and the peptide Sos.
Xue Y; Yuwen T; Zhu F; Skrynnikov NR
Biochemistry; 2014 Oct; 53(41):6473-95. PubMed ID: 25207671
[TBL] [Abstract][Full Text] [Related]
10. The role of covalent dimerization on the physical and chemical stability of the EC1 domain of human E-cadherin.
Trivedi M; Davis RA; Shabaik Y; Roy A; Verkhivker G; Laurence JS; Middaugh CR; Siahaan TJ
J Pharm Sci; 2009 Oct; 98(10):3562-74. PubMed ID: 19199298
[TBL] [Abstract][Full Text] [Related]
11. Combined use of replica-exchange molecular dynamics and magic-angle-spinning solid-state NMR spectral simulations for determining the structure and orientation of membrane-bound peptide.
Ikeda K; Kameda T; Harada E; Akutsu H; Fujiwara T
J Phys Chem B; 2011 Jul; 115(29):9327-36. PubMed ID: 21668001
[TBL] [Abstract][Full Text] [Related]
12. Deep analysis of N-cadherin/ADH-1 interaction: a computational survey.
Eslami M; Nezafat N; Khajeh S; Mostafavi-Pour Z; Bagheri Novir S; Negahdaripour M; Ghasemi Y; Razban V
J Biomol Struct Dyn; 2019 Jan; 37(1):210-228. PubMed ID: 29301458
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VII.
Hu CK; Llinás M; Agner KE; Orning L; Sakariassen KS; Fischer PM
J Pept Res; 2001 Jun; 57(6):462-72. PubMed ID: 11437950
[TBL] [Abstract][Full Text] [Related]
14. Investigating the Structural Variability and Binding Modes of the Glioma Targeting NFL-TBS.40-63 Peptide on Tubulin.
Laurin Y; Savarin P; Robert CH; Takahashi M; Eyer J; Prevost C; Sacquin-Mora S
Biochemistry; 2015 Jun; 54(23):3660-9. PubMed ID: 26016807
[TBL] [Abstract][Full Text] [Related]
15. Cadherin mechanics and complexation: the importance of calcium binding.
Cailliez F; Lavery R
Biophys J; 2005 Dec; 89(6):3895-903. PubMed ID: 16183887
[TBL] [Abstract][Full Text] [Related]
16. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
Liu ZP; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
[TBL] [Abstract][Full Text] [Related]
17. Towards understanding the molecular recognition process in prokaryotic zinc-finger domain.
Russo L; Palmieri M; Caso JV; D'Abrosca G; Diana D; Malgieri G; Baglivo I; Isernia C; Pedone PV; Fattorusso R
Eur J Med Chem; 2015 Feb; 91():100-8. PubMed ID: 25240418
[TBL] [Abstract][Full Text] [Related]
18. Dynamic properties of a type II cadherin adhesive domain: implications for the mechanism of strand-swapping of classical cadherins.
Miloushev VZ; Bahna F; Ciatto C; Ahlsen G; Honig B; Shapiro L; Palmer AG
Structure; 2008 Aug; 16(8):1195-205. PubMed ID: 18682221
[TBL] [Abstract][Full Text] [Related]
19. Cyclic beta-helical/beta-hairpin D,L-alpha-peptide: study of its folding properties and structure refinement using molecular dynamics.
Meier K; van Gunsteren WF
J Phys Chem A; 2010 Feb; 114(4):1852-9. PubMed ID: 20055405
[TBL] [Abstract][Full Text] [Related]
20. Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin.
Sinaga E; Jois SD; Avery M; Makagiansar IT; Tambunan US; Audus KL; Siahaan TJ
Pharm Res; 2002 Aug; 19(8):1170-9. PubMed ID: 12240943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
